BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 125 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,601,384 | +1.6% | 649,913 | +1.1% | 0.00% | +100.0% |
Q2 2023 | $4,526,981 | +62.3% | 643,037 | +92.3% | 0.00% | 0.0% |
Q1 2023 | $2,788,804 | -70.8% | 334,389 | -59.8% | 0.00% | -66.7% |
Q4 2022 | $9,555,000 | +46.2% | 832,325 | +60.5% | 0.00% | +50.0% |
Q3 2022 | $6,535,000 | +148.8% | 518,702 | +108.9% | 0.00% | +100.0% |
Q2 2022 | $2,627,000 | +20.3% | 248,283 | +85.0% | 0.00% | 0.0% |
Q1 2022 | $2,183,000 | +190.7% | 134,228 | +182.7% | 0.00% | – |
Q2 2021 | $751,000 | +46.7% | 47,483 | -5.7% | 0.00% | – |
Q1 2021 | $512,000 | -2.5% | 50,334 | -28.7% | 0.00% | – |
Q4 2020 | $525,000 | +201.7% | 70,574 | +39.4% | 0.00% | – |
Q3 2020 | $174,000 | -54.3% | 50,624 | -36.7% | 0.00% | – |
Q2 2020 | $381,000 | +1.1% | 79,966 | -26.6% | 0.00% | – |
Q4 2019 | $377,000 | +50.8% | 109,019 | +25.0% | 0.00% | – |
Q3 2019 | $250,000 | -73.8% | 87,250 | -26.2% | 0.00% | – |
Q4 2018 | $954,000 | – | 118,223 | +393976.7% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 30 | -99.0% | 0.00% | – |
Q3 2013 | $22,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |